Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-15-001289
Filing Date
2015-08-13
Accepted
2015-08-13 15:14:22
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-Q boston10q.htm 10-Q 708172
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 17148
3 EXHIBIT 31.2 exh31_2.htm EX-31.2 17236
4 EXHIBIT 32.1 exh32_1.htm EX-32.1 7143
5 EXHIBIT 31.2 exh32_2.htm EX-32.2 7140
  Complete submission text file 0001102624-15-001289.txt   3358368

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bthe-20150630.xml EX-101.INS 596494
7 XBRL TAXONOMY EXTENSION SCHEMA bthe-20150630.xsd EX-101.SCH 35814
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bthe-20150630_cal.xml EX-101.CAL 44052
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bthe-20150630_def.xml EX-101.DEF 95799
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bthe-20150630_lab.xml EX-101.LAB 255800
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bthe-20150630_pre.xml EX-101.PRE 196711
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54586 | Film No.: 151050339
SIC: 2834 Pharmaceutical Preparations